OB/GYN doctor wants to change perceptions that incontinence is 'just a product of aging' by providing innovative solutions.
Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
NASHVILLE, Tenn. (Ivanhoe Newswire) – It’s a taboo topic that nobody talks about but, almost one in six Americans suffer with urinary or bowel incontinence. That’s more than the number of people with ...
Medtronic’s InterStim X neuromodulation device can be implanted for at least 10 years without requiring a recharge, and potentially up to 15 years if energy-saving settings are used. (Medtronic) ...
Medtronic continues to up its game in sacral neuromodulation. FDA approved InterStim X, the next generation of the company's InterStim portfolio's recharge-free device. Medtronic said implants have ...
Add Us On GoogleAdd as a preferred source on Google (WNDU) - It’s a taboo topic that nobody talks about. But 1 in 6 Americans suffer with either urinary or bowel incontinence. That’s more than the ...
DUBLIN, March 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study that will evaluate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results